TONIX PHARMACEUTICALS

Serial Number 98577945
645

Registration Progress

Application Filed
May 31, 2024
Under Examination
Approved for Publication
Published for Opposition
Registered

Attorney Assistance

Final Refusal E-Mailed
Due: Aug 05, 2025 15 days

Trademark Image

TONIX PHARMACEUTICALS

Basic Information

Serial Number
98577945
Filing Date
May 31, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
645
Status Date
May 5, 2025
Application
Pending
Classes
005

Rights Holder

TONIX PHARMACEUTICALS, INC.

03
Address
26 Main Street Suite 101
Chatham, NJ 07928

Ownership History

TONIX PHARMACEUTICALS, INC.

Original Applicant
03
Chatham, NJ

Legal Representation

Attorney
Francis J. Duffin

USPTO Deadlines

Next Deadline
15 days remaining
Final Refusal E-Mailed
Due Date
August 05, 2025
Extension Available
Until November 05, 2025

Application History

14 events
Date Code Type Description Documents
Jul 18, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jul 18, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
May 5, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 5, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
May 5, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Mar 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Mar 14, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 16, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 16, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 16, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 12, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 14, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 31, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, and for treating and preventing viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMACEUTICALS"